Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study

Key Points

• Combination therapy demonstrated acceptable safety profiles with minimal adverse events observed.
• Of 150 females, 80% reported improved hair density after 6 months of treatment.
• Retrospective cohort analysis involved assessing medical records over a 12-month period.
• Findings support the use of spironolactone and low-dose minoxidil for those experiencing hair loss.